|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Current assets: | |||||||||||||||
| Cash and cash equivalents | |||||||||||||||
| Short-term investments | |||||||||||||||
| Accounts receivable, net | |||||||||||||||
| Other receivables due from related parties | |||||||||||||||
| Inventories | |||||||||||||||
| Income tax receivable | |||||||||||||||
| Other current assets | |||||||||||||||
| Prepaid and other current assets | |||||||||||||||
| Total current assets | |||||||||||||||
| Property, equipment and software, net | |||||||||||||||
| Goodwill | |||||||||||||||
| Deferred income taxes | |||||||||||||||
| Other assets | |||||||||||||||
| Total assets | |||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||
| Current liabilities: | |||||||||||||||
| Accounts payable due to related parties | |||||||||||||||
| Accounts payable | |||||||||||||||
| Related Party | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Total accounts payable | |||||||||||||||
| Accrued expenses | |||||||||||||||
| Accrued royalties | |||||||||||||||
| Income taxes payable | |||||||||||||||
| Other current liabilities | |||||||||||||||
| Total current liabilities | |||||||||||||||
| Other long-term liabilities | |||||||||||||||
| Total liabilities | |||||||||||||||
| Stockholders’ equity: | |||||||||||||||
| Preferred stock, $0.0001 par value; 100.0 shares authorized and no shares issued and outstanding as of September 30, 2024 and December 31, 2023 | |||||||||||||||
| Preferred stock | |||||||||||||||
| Series A convertible preferred stock | |||||||||||||||
| Total preferred stock, $0.0001 par value; 100.0 shares authorized and no shares issued and outstanding as of September 30, 2024 and December 31, 2023 | |||||||||||||||
| Common stock, $0.0001 par value; 1,350.0 shares authorized as of September 30, 2024 and December 31, 2023 Class A, 127.2 and 125.3 shares issued and 127.2 and 121.5 shares outstanding as of September 30, 2024 and December 31, 2023, respectively Class B, 75.3 and 76.2 shares issued and 75.3 and 76.2 shares outstanding as of September 30, 2024 and December 31, 2023, respectively Class C, no shares issued and outstanding as of September 30, 2024 and December 31, 2023 | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated other comprehensive loss | |||||||||||||||
| Retained earnings | |||||||||||||||
| Total stockholders’ equity | |||||||||||||||
| Total liabilities and stockholders’ equity | |||||||||||||||
Loading...
